Squamous cell carcinoma (SCC) of skin is an uncontrolled growth of cells of epithelium commonly seen in males in fifth to sixth decade of life. Risk factors include fair skin, blonde hair, exposure to sunlight (ultraviolet B), immunosuppression, human papillomavirus, and genetics. Surface mold brachytherapy (SMB) is a well-established treatment for early stage head and neck cancers involving accessible sites. It has evolved from the radium era to low-dose rate and now to high-dose rate intensity-modulated interventional brachytherapy. We present a 50-year-old male patient with squamous carcinoma of the left lower eyelid and was operated for the same. Histopathology was well-differentiated SCC with all positive margins. The patient was then treated by SMB and evaluated for toxicity, local control, and survival. week for a total dose ranging from 1600 to 5000 cGy (4-13 fractions).
Introduction

S
kin cancers of the eyelid account for 5%−10% of all skin cancers. Basal cell carcinoma (BCC) is the most common eyelid tumor reported in western population and accounts for 90% of all eyelid malignancies. [1] It most frequently occurs in the lower eyelid (50%−66%) and medial canthus (25%−30%). Surgical excision, Mohs micrographic surgery, cryosurgery, and radiotherapy have all been reported to achieve 5 years' cure rates of 90% or higher in BCC. [2, 3] Squamous cell carcinoma (SCC) accounts for <5% of eyelid malignancies. Surface mold therapy was introduced at the beginning of the 20 th century to treat skin lesions following the discovery of radium. [4] Radioactive mold became one of the established modalities to treat skin cancer along with superficial and orthovoltage X-rays. [5] The development of after loading techniques and in particular high-dose rate (HDR) remote after loader overcame the issues associated with personal radiation protection. HDR surface mold brachytherapy (SMB) was first introduced by Joslin. [6, 7] Depending on the site, histology and adjuvant or primary treatment patients are treated with a dose of 300-500 cGy per fraction twice a How to cite this article: Jain VS, Kushwah V, Chaitali PW, Mukund BS. High-dose rate surface mold brachytherapy in a case of squamous cell carcinoma of lower eyelid: A case report from a rural cancer center of Maharashtra. J Radiat Cancer Res 2019;10:124-7.
by perforated thermoplastic sheet to immobilize the head during each fraction and to keep SMB applicator in place was made, and the mold assembly area was cut as shown in Figure 3 . Scar being adjacent to eyeball, cornea, and lens the mold was prepared with extra care with wax strips. Two plastic needles were mounted over the mold at 7 mm distance [ Figure 3 ]. As per the necessity, adhesive tape was used to fix the mold in position for comfortable fitting during treatment. TPS planning was done on Brachyvision (Eclipse brachytherapy planning 8.1.20, Varian medical systems).
Step distance of source was 5 mm; total treatment length was 3 and 2.5 cm in 1 st and 2 nd needles. The dose was prescribed at 4 mm depth. The total dose delivered was 40 Gy in 10 fractions, twice weekly over 5 weeks' duration. Homogeneous dose distribution was achieved at the desired depth of eyelid with an adequate margin as shown in transverse and coronal plan [Figures 4 and 5] . The patient was instructed to look up at the time of brachytherapy treatment, so as to increase the distance of lens and cornea from mold (dose area).
The mold with catheters in situ was to be connected to the treatment machine during radiation treatment.
During and on completion of the treatment, the patient was regularly followed in the department and with the ophthalmologist and was prescribed eye drops and topical steroid ointments [ Figure 6 ]. The radiation-related toxicities were classified according to the Radiation Therapy Oncology Group grading system. The first review was done at 6 weeks from completion, then at every 3 months, till 2 years, and then 6 monthly. On follow-up, the clinical and ophthalmological examination was undertaken, and further investigations were done only if required clinically. Pre-and post-radiotherapy visual evaluation and cosmetic outcome were done. The last follow-up was on March 2019 with no evidence of any local or distant failure [ Figure 7 ].
Results and Discussion
With custom-made surface mold, the dose distribution was uniform over the surface of the skin and at 5 mm depth in the desired surface volume to be treated. The treatment tolerance was excellent, and the patient was disease free at the 40 th month follow-up [ Figure 7 ]. It arises from the keratinocytes. BCC and SCC of the skin account for 90% of skin cancers. Of this 90%, approximately 5%-10% arise in the eyelid region. Surgery is the primary treatment for most of the skin carcinomas with good results. Skin carcinomas located on the nose, eyelid, ear, and any other face region surgical excision might be difficult due to cosmetic reasons. Cosmetic surgeries with good margins require anesthesia with high risk for patient life. This is particularly the issue in the elderly and frail patients. However, in the presence of certain high-risk factors, adjuvant radiotherapy is indicated postoperatively. [9, 10] Radiotherapy treatment for nonmelenomatous skin cancers as primary or adjuvant therapy can be delivered by orthovoltage X-rays, Electron beam, HDR SMB, and interstitial brachytherapy.
Electron-beam therapy is preferred in the treatment of skin carcinomas. HDR SMB offers an alternative radiotherapy modality to electrons for the treatment of superficial tumors. The HDR mold, due to its flexibility, is able to conform well to the skin area and the dose can be delivered uniformly at depth when treating curved surfaces as well. The electron cones, on the other hand, are rigid and as a result, there can be appreciable variations in the treatment source to skin distance across the treatment area. Obliquity effects for electrons [8, 11] when incident on curved surfaces can further contribute to the dose inhomogeneity at depth. With electron-beam therapy, there are air gaps between the patient surface and electron cone specifically over curved surfaces.
SMB is a well-established treatment for the surface tumors of the head and neck region and used since many decades. In the series reported by Budrukkar et al. [12, 13] for skin malignancies 5 years' local control rate was 92%. Only one out of 14 patients, recurrence was observed after 8 months, and the tumor was located over the nose. Similarly, in another series, reported by Maroñas et al. [14] all five patients who had recurred (of total 48) the tumor was located over the nose. The dose schedule used by both the authors was 3-4 Gy per fraction twice daily; 6 h apart, the total dose varies from 38.5 Gy to 52.5 Gy in 11-15 fractions over 1-2 weeks' time.
Similar reports by Musmacher et al. [15] and Sabbas et al. [8] for the treatment of skin malignancies by SMB shows good results, but the dose schedule used by them was 4-5 Gy per fraction twice weekly for 4-5 weeks (total dose 40-50 Gy in 10-12 fractions over 4-5 weeks). They noticed less acute reactions and late toxicities.
The advantage of spreading dose over 4-6 weeks as per conventional plans can be achieved with SMB as compared to interstitial brachytherapy in which placement of needles/wires/applicators is required, and dose is delivered by twice daily fractionation schedule over 1 week time, till then applicators remain in place. For eyelid tumors, interstitial brachytherapy has also been used by Manghani and Khan [9] with acute and late toxicities even corneal ulcers were also reported. Advantages of SMB over interstitial brachytherapy are dose can be very well spread over a time, so that reactions are less and trauma of keeping catheters over a week time can be avoided.
Conclusion
Radiotherapy is a highly effective treatment of skin carcinomas of the face and body. The surface mold used in conjunction with HDR brachytherapy makes it possible to deliver a uniform dose distribution at the desired depth and area; treating only the surface and sparing deeper structures. Local control is excellent with minimal complications. Various advantages of SMB are easy conformability of the treatment surface; dose fall-off is faster and accurate reproducibility during each treatment. Short treatment time (few minutes) once molds preparation and treatment planning is done. Treatment delivery is on outpatient department basis.
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